
COST-EFFECTIVENESS OF ROSUVASTATIN/EZETIMIBE THERAPY IN HIGH-RISK HYPERTENSIVE PATIENTS WITH UNCONTROLLED HYPERCHOLESTEROLEMIA BY A PREVIOUS SIMVASTATIN/EZETIMIBE TREATMENT
Author(s) -
Alberto Mazza,
Gioia Torin,
C. D’Amicis,
Laura Schiavon,
Antonella Paola Sacco,
Salvatore Lenti
Publication year - 2019
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000572928.62289.98
Subject(s) - ezetimibe , medicine , fixed dose combination , combination therapy , tolerability , rosuvastatin , simvastatin , urology , statin , gastroenterology , adverse effect